OncologyTube Professional - Patients Click Here
275,610 video views
Loading........
Description: Patient-reported outcomes (PROs) give a greater insight into the lives of patients and their perspectives on the treatment received. Here, Suwicha Limvorasak, PharmD, BCOP, from the Cedars-Sinai Medic...
03:45
Patient-reporte​d outcomes (PROs) give a greater insight into the lives of patients and their perspectives on the treatment received. Here, Suwicha Limvorasak, PharmD, BCOP, from the Cedars-Sinai Medical Center, Los Angeles, CA, explains how older PRO measures, such as questionnaires that are current...
by:VJOncology | 8 views
02:30
The androgen synthesis inhibitor abiraterone increases the survival of men with metastatic prostate cancer; however, existing clinical trials consistently over-represent Caucasian men. Here, Andrew Armstrong, MD, of Duke University, Durham, NC, presents the findings of his recent study, which aimed ...
by:VJOncology | 6 views
02:39
A large proportion of gynecological tumors are classed as rare tumors because of their variable morphologies and pathologies. We interviewed Marcia Hall, MBBS, PhD, FRCP, of the East and North Hertfordshire NHS Trust, Hertfordshire, UK, about these rare tumors at the UK Oncology Forum (OF) 2018, hel...
by:VJOncology | 22 views
01:20
Collaboration for Oncology Data in Europe (CODE) is an alliance that brings together patient associations, charities and treatment centers in Europe. The main aim of CODE is to help build a pan-European oncology data network to facilitate data sharing. Here, Ashley Woolmore, Initiative Lead for CODE...
by:VJOncology | 48 views
03:52
Marianne Nicolson, MD, FRCP, BSc, MBChB, of NHS Grampian, Aberdeen, UK, gives an overview of a session discussing lung cancer that she chaired at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. Prof. Nicolson gives a summary of the updates from the session, referencing a number of speakers, including Mariam Jamal-Hanjani, who spoke about he...
by:VJOncology | 38 views
01:05
The integration of scientific research into clinical practice is one of the many challenges healthcare professionals face. Here, Mariam Jamal-Hanj, BSc, MBBS, PhD, of University College London, London, UK, discusses the implementation of longitudinal studies, such as TRACERx (NCT01888601) and PEACE (NCT03004755), into the real world in the context ...
by:VJOncology | 29 views
01:02
Vicky Coyle, MD, of Queen's University Belfast, Belfast, UK, spoke to us at the UK Oncology Forum (OF) 2018, held in Liverpool, UK, about the benefits of physical activity in the adjuvant setting. She discusses her current trial exploring the role of exercise as a treatment after standard chemotherapy and surgery for stage II and III colon cancer. ...
by:VJOncology | 39 views
02:19
Mariam Jamal-Hanj, BSc, MBBS, PhD, of University College London, London, UK, discusses her talk regarding intra-tumor heterogeneity within lung cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She highlights the significance of longitudinal studies, such as TRACERx (NCT01888601) and...
by:VJOncology | 33 views
02:01
Aspirin has been suggested as a preventative measure for several cancer types, in particular colorectal cancer, as Vicky Coyle, MD, of Queen's University Belfast, Belfast, UK, explains at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. She describes a current trial that aims to identify the ...
by:VJOncology | 19 views
01:39
Kai-Keen Shiu, MRCP, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about future directions for the treatment of rectal cancer at the UK Oncology Forum (OF) 2018, held in Liverpool, UK. He discusses the possibility of a new treatment strategy using total neoadjuvant therapy with reduced oxaliplatin dosage...
by:VJOncology | 13 views

About VJOncology
Description: The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of solid tumors. Our goal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media – including video and blog formats. VJOncology content will be led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of solid tumors. All content will be created and published under the guidance of this board of world-leading experts.

Links
Channel Url: